Shares of Insulet (NASDAQ: PODD) , a medical device company, are jumping in response to regulatory approval of a new product . Investors excited about the company's new automated insulin delivery system pushed the stock 15% higher as of 11:57 a.m. ET on Friday.
Today the company announced the FDA has finally approved OmniPod 5 after several long delays. Omnipod 5 is the first tubeless automated insulin delivery system that integrates with a popular continuous glucose monitor from DexCom (NASDAQ: DXCM) .
Image source: Getty Images.
For further details see:
Here's Why Insulet Stock Is Jumping Higher on Friday